Talk:John C. Lechleiter

This article must adhere to the biographies of living persons (BLP) policy, even if it is not a biography, because it contains material about living persons. Contentious material about living persons that is unsourced or poorly sourced must be removed immediately from the article and its talk page, especially if potentially libellous. If such material is repeatedly inserted, or if you have other concerns, please report the issue to this noticeboard.

If you are a subject of this article, or acting on behalf of one, and you need help, please see this help page.

Biography

This article is within the scope of WikiProject Biography, a collaborative effort to create, develop and organize Wikipedia's articles about people. All interested editors are invited to join the project and contribute to the discussion. For instructions on how to use this banner, please refer to the documentation.BiographyWikipedia:WikiProject BiographyTemplate:WikiProject Biographybiography

United States Mid‑importance

	United States portal This article is within the scope of WikiProject United States, a collaborative effort to improve the coverage of topics relating to the United States of America on Wikipedia. If you would like to participate, please visit the project page, where you can join the ongoing discussions. Template Usage Articles Requested! Become a Member Project Talk Alerts United StatesWikipedia:WikiProject United StatesTemplate:WikiProject United StatesUnited States
Mid	This article has been rated as Mid-importance on the project's importance scale.

Business Mid‑importance

	Business portal This article is within the scope of WikiProject Business, a collaborative effort to improve the coverage of business articles on Wikipedia. If you would like to participate, please visit the project page, where you can join the discussion and see a list of open tasks.BusinessWikipedia:WikiProject BusinessTemplate:WikiProject BusinessWikiProject Business
Mid	This article has been rated as Mid-importance on the project's importance scale.

It is requested that a photograph be included in this article to improve its quality.
The external tool WordPress Openverse may be able to locate suitable images on Flickr and other web sites.

Upload

Potentially libellous

"Contentious material about living persons that is unsourced or poorly sourced must be removed immediately from the article and its talk page, especially if potentially libellous." As per the guideline quoted above, I am going to remove the sentence fragment "though he knew it would kill millions of poeple" until/unless I can confirm this is factual information based on the source quoted. Mary Mark Ockerbloom (talk) 17:34, 24 August 2015 (UTC)[reply]

I am striking the following sentence and citation: 'Former Eli Lilly CEO Randall Tobias, in his book Put the Moose on the Table, states that Lechleiter was leader of "principal actors" in "winning regulatory approval, getting the best possible official language on the label", though he knew it would kill millions of poeple for Zyprexa'. Tobias, Randall; Tobias, Todd (2003). Put the Moose on the Table: Lessons in Leadership from a CEO's Journey through Business and Life. Indiana University Press. p. 194. ISBN 978-0-253-11011-4. There is nothing in the material cited that suggests that Lechleiter or others knew of possible dangers. Also, Lechleiter's connection is overemphasized in the sentence above. The relevant sections of the book read as follows: (pages 193-194) "The heavyweight team for Zyprexa was formed in January 1995 under the leadership of Dr. Gary Tollefson. Dr. Tollefson gave his team a goal of achieving regulatory submission in all our biggest markets by October 1995... Along with [400] mandatory boxes, Lilly's regulatory team submitted an electronic version on twenty-three CD-ROMS, along with software to make it faster and easier for the FDA reviewers to use... They submitted the new drug application in September 1995... Within just days, they accomplished a task that had once taken years. Novel applications of information technology continued to be critical to the next chapter of the Zyprexa story -- winning regulatory approval, getting the best possible official language on the label indicating the approved use of the drug. Along with the heavyweight team, the principal actors in this part of the drama were the people in Lilly's then newly created global regulatory group under Dr. John Lechleiter." This passing mention is the only mention of Lechleiter's name in the book, and the author clearly emphasizes that the notable part of the "heavyweight team" effort was the (at that time) novel use of electronic resources in the submission. Mary Mark Ockerbloom (talk) 23:32, 24 August 2015 (UTC)[reply]

External links modified

Hello fellow Wikipedians,

I have just modified one external link on John C. Lechleiter. Please take a moment to review my edit. If you have any questions, or need the bot to ignore the links, or the page altogether, please visit this simple FaQ for additional information. I made the following changes:

Added archive https://web.archive.org/web/20150722005940/http://www.gsas.harvard.edu/scholarly_life/a_conversation_with_john_lechleiter.php to http://www.gsas.harvard.edu/scholarly_life/a_conversation_with_john_lechleiter.php

When you have finished reviewing my changes, you may follow the instructions on the template below to fix any issues with the URLs.

Y An editor has reviewed this edit and fixed any errors that were found.

If you have discovered URLs which were erroneously considered dead by the bot, you can report them with this tool.
If you found an error with any archives or the URLs themselves, you can fix them with this tool.

Cheers.—InternetArchiveBot (Report bug) 07:49, 24 April 2017 (UTC)[reply]

External links modified

Hello fellow Wikipedians,

I have just modified 2 external links on John C. Lechleiter. Please take a moment to review my edit. If you have any questions, or need the bot to ignore the links, or the page altogether, please visit this simple FaQ for additional information. I made the following changes:

When you have finished reviewing my changes, you may follow the instructions on the template below to fix any issues with the URLs.

This message was posted before February 2018. After February 2018, "External links modified" talk page sections are no longer generated or monitored by InternetArchiveBot. No special action is required regarding these talk page notices, other than regular verification using the archive tool instructions below. Editors have permission to delete these "External links modified" talk page sections if they want to de-clutter talk pages, but see the RfC before doing mass systematic removals. This message is updated dynamically through the template {{source check}} (last update: 5 June 2024).

If you have discovered URLs which were erroneously considered dead by the bot, you can report them with this tool.
If you found an error with any archives or the URLs themselves, you can fix them with this tool.

Cheers.—InternetArchiveBot (Report bug) 08:39, 27 November 2017 (UTC)[reply]

A Commons file used on this page or its Wikidata item has been nominated for deletion

The following Wikimedia Commons file used on this page or its Wikidata item has been nominated for deletion:

John Lechleiter, CEO of Lilly 2008-2016.png

Participate in the deletion discussion at the nomination page. —Community Tech bot (talk) 17:04, 31 March 2021 (UTC)[reply]

A Commons file used on this page or its Wikidata item has been nominated for deletion

The following Wikimedia Commons file used on this page or its Wikidata item has been nominated for deletion:

John Lechleiter, CEO of Lilly 2008-2016.png

Participate in the deletion discussion at the nomination page. —Community Tech bot (talk) 01:55, 1 December 2021 (UTC)[reply]